These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 21738339)

  • 1. Detecting the recurrence of gastric cancer after curative resection: comparison of FDG PET/CT and contrast-enhanced abdominal CT.
    Kim DW; Park SA; Kim CG
    J Korean Med Sci; 2011 Jul; 26(7):875-80. PubMed ID: 21738339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of recurrence in gastric carcinoma: Comparison of contrast-enhanced computed tomography and positron emission tomography/computed tomography.
    Kim JH; Heo SH; Kim JW; Shin SS; Min JJ; Kwon SY; Jeong YY; Kang HK
    World J Gastroenterol; 2017 Sep; 23(35):6448-6456. PubMed ID: 29085194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDG-PET/contrast-enhanced CT as a post-treatment tool in head and neck squamous cell carcinoma: comparison with FDG-PET/non-contrast-enhanced CT and contrast-enhanced CT.
    Suenaga Y; Kitajima K; Ishihara T; Sasaki R; Otsuki N; Nibu K; Minamikawa T; Kiyota N; Sugimura K
    Eur Radiol; 2016 Apr; 26(4):1018-30. PubMed ID: 26188656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of PET/CT in detection of gastric cancer recurrence.
    Sim SH; Kim YJ; Oh DY; Lee SH; Kim DW; Kang WJ; Im SA; Kim TY; Kim WH; Heo DS; Bang YJ
    BMC Cancer; 2009 Mar; 9():73. PubMed ID: 19250554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of 18F-FDG PET/CT in the evaluation of gastric cancer recurrence after curative gastrectomy.
    Lee JE; Hong SP; Ahn DH; Jeon TJ; Kang MK; Kwon CI; Ko KH; Hwang SG; Park PW; Rim KS
    Yonsei Med J; 2011 Jan; 52(1):81-8. PubMed ID: 21155039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of (18)F-FDG PET/CT as a postoperative surveillance imaging modality for asymptomatic advanced gastric cancer patients.
    Lee DY; Lee CH; Seo MJ; Lee SH; Ryu JS; Lee JJ
    Ann Nucl Med; 2014 Oct; 28(8):789-95. PubMed ID: 24965850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of (18) F-FDG PET/CT and CECT in conjunction with serum CA 19-9 for detecting recurrent pancreatic adenocarcinoma.
    Rayamajhi S; Balachandran A; Katz M; Reddy A; Rohren E; Bhosale P
    Abdom Radiol (NY); 2018 Feb; 43(2):505-513. PubMed ID: 28900703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
    Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
    Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic performance of contrast enhanced CT and 18F-FDG PET/CT in suspicious recurrence of biliary tract cancer after curative resection.
    Lee YG; Han SW; Oh DY; Chie EK; Jang JY; Im SA; Kim TY; Kim SW; Ha SW; Bang YJ
    BMC Cancer; 2011 May; 11():188. PubMed ID: 21599995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical utility of positron emission tomography/computed tomography in the evaluation of suspected recurrent ovarian cancer in the setting of normal CA-125 levels.
    Bhosale P; Peungjesada S; Wei W; Levenback CF; Schmeler K; Rohren E; Macapinlac HA; Iyer RB
    Int J Gynecol Cancer; 2010 Aug; 20(6):936-44. PubMed ID: 20683399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of combined PET/CT to assess regional lymph node involvement in gastric cancer.
    Park K; Jang G; Baek S; Song H
    Tumori; 2014; 100(2):201-6. PubMed ID: 24852866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of (18) F-FDG-PET/CT imaging in oral cavity cancer patients following surgical reconstruction.
    Müller J; Hüllner M; Strobel K; Huber GF; Burger IA; Haerle SK
    Laryngoscope; 2015 Aug; 125(8):1861-8. PubMed ID: 25892275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in post-operative follow up of gastric cancer: initial results.
    Sun L; Su XH; Guan YS; Pan WM; Luo ZM; Wei JH; Wu H
    World J Gastroenterol; 2008 Aug; 14(29):4627-32. PubMed ID: 18698676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of FDG-PET/CT in ovarian cancer patients with high tumor markers or suspicious lesion on contrast-enhanced CT in evaluation of recurrence and/or in determination of intraabdominal metastases.
    Sari O; Kaya B; Kara PO; Gedik GK; Celik C; Ozbek O; Serdengecti M
    Rev Esp Med Nucl Imagen Mol; 2012; 31(1):3-8. PubMed ID: 21549452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Added value of pretreatment (18)F-FDG PET/CT for staging of advanced gastric cancer: Comparison with contrast-enhanced MDCT.
    Kawanaka Y; Kitajima K; Fukushima K; Mouri M; Doi H; Oshima T; Niwa H; Kaibe N; Sasako M; Tomita T; Miwa H; Hirota S
    Eur J Radiol; 2016 May; 85(5):989-95. PubMed ID: 27130061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detecting recurrence of gastric cancer: the value of FDG PET/CT.
    Park MJ; Lee WJ; Lim HK; Park KW; Choi JY; Kim BT
    Abdom Imaging; 2009 Jul; 34(4):441-7. PubMed ID: 18543017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of recurrent ovarian cancer at MRI: comparison with integrated PET/CT.
    Kim CK; Park BK; Choi JY; Kim BG; Han H
    J Comput Assist Tomogr; 2007; 31(6):868-75. PubMed ID: 18043348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic performance of FDG PET/CT for surveillance in asymptomatic gastric cancer patients after curative surgical resection.
    Lee JW; Lee SM; Son MW; Lee MS
    Eur J Nucl Med Mol Imaging; 2016 May; 43(5):881-888. PubMed ID: 26611426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between the diagnostic accuracies of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and conventional imaging in recurrent urothelial carcinomas: a retrospective, multicenter study.
    Zattoni F; Incerti E; Colicchia M; Castellucci P; Panareo S; Picchio M; Fallanca F; Briganti A; Moschini M; Gallina A; Karnes JR; Lowe V; Fanti S; Schiavina R; Rambaldi I; Ficarra V; Evangelista L
    Abdom Radiol (NY); 2018 Sep; 43(9):2391-2399. PubMed ID: 29302738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical management of patients with bowel obstructions secondary to gastric cancer.
    Wu WG; Dong P; Wu XS; Li ML; Ding QC; Zhang L; Yang JH; Weng H; Ding Q; Tan ZJ; Lu JH; Gu J; Liu YB
    World J Gastroenterol; 2013 Jul; 19(28):4559-67. PubMed ID: 23901233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.